Christopher V Almario1,1,1,1,1, Megana L Ballal1, William D Chey1, Carl Nordstrom1, Dinesh Khanna1, Brennan M R Spiegel1,1,1,1,1. 1. Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Division of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Division of Health Services Research, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Los Angeles, CA, USA. Division of Informatics, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Division of Gastroenterology, Michigan Medicine, Ann Arbor, MI, USA. Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Division of Rheumatology, Michigan Medicine, Ann Arbor, MI, USA. Department of Health Policy and Management, UCLA Fielding School of Public Health, Los Angeles, CA, USA.
Abstract
OBJECTIVES: Digestive diseases account for >100 million ambulatory care visits annually in the U.S. Yet, comparatively less is known about the true burden of gastrointestinal (GI) symptoms in the general U.S. POPULATION: The aim of this study was to use data from the "National GI Survey"-a population-based audit of GI symptoms in >71,000 participants-to determine the prevalence and predictors of GI symptoms in community-dwelling Americans. METHODS: We conducted the National GI Survey using a mobile app called MyGiHealth, which employs a computer algorithm that systematically collects participants' GI symptoms. We recruited a nationally representative sample of Americans to complete the survey, which guided respondents through National Institutes of Health (NIH) GI Patient Reported Outcome Measurement Information System (PROMIS®) scales along with questions about relevant comorbidities and demographics. We measured the prevalence of GI symptoms in the past week and employed logistic regression to adjust for confounding. RESULTS: Overall, 71,812 individuals completed the survey, of which 61% reported having had ≥1 GI symptom in the past week. The most commonly reported symptoms were heartburn/reflux (30.9%), abdominal pain (24.8%), bloating (20.6%), diarrhea (20.2%), and constipation (19.7%). Less common symptoms were nausea/vomiting (9.5%), dysphagia (5.8%), and bowel incontinence (4.8%). Females, non-Hispanic whites, and individuals who were younger, highly educated, and had medical comorbidities were more likely to have symptoms (all adjusted p < 0.05). CONCLUSIONS: In this large population-based study that combined digital health technology with NIH PROMIS questionnaires, we found that GI symptoms are highly prevalent, as nearly two thirds of surveyed Americans are burdened by these symptoms.
OBJECTIVES: Digestive diseases account for >100 million ambulatory care visits annually in the U.S. Yet, comparatively less is known about the true burden of gastrointestinal (GI) symptoms in the general U.S. POPULATION: The aim of this study was to use data from the "National GI Survey"-a population-based audit of GI symptoms in >71,000 participants-to determine the prevalence and predictors of GI symptoms in community-dwelling Americans. METHODS: We conducted the National GI Survey using a mobile app called MyGiHealth, which employs a computer algorithm that systematically collects participants' GI symptoms. We recruited a nationally representative sample of Americans to complete the survey, which guided respondents through National Institutes of Health (NIH) GI Patient Reported Outcome Measurement Information System (PROMIS®) scales along with questions about relevant comorbidities and demographics. We measured the prevalence of GI symptoms in the past week and employed logistic regression to adjust for confounding. RESULTS: Overall, 71,812 individuals completed the survey, of which 61% reported having had ≥1 GI symptom in the past week. The most commonly reported symptoms were heartburn/reflux (30.9%), abdominal pain (24.8%), bloating (20.6%), diarrhea (20.2%), and constipation (19.7%). Less common symptoms were nausea/vomiting (9.5%), dysphagia (5.8%), and bowel incontinence (4.8%). Females, non-Hispanic whites, and individuals who were younger, highly educated, and had medical comorbidities were more likely to have symptoms (all adjusted p < 0.05). CONCLUSIONS: In this large population-based study that combined digital health technology with NIH PROMIS questionnaires, we found that GI symptoms are highly prevalent, as nearly two thirds of surveyed Americans are burdened by these symptoms.
Authors: Christopher V Almario; Alison A Almario; Maria Elena Cunningham; Joshua Fouladian; Brennan M R Spiegel Journal: Clin Gastroenterol Hepatol Date: 2017-03-23 Impact factor: 11.382
Authors: Christopher V Almario; William D Chey; Sentia Iriana; Francis Dailey; Karen Robbins; Anish V Patel; Mark Reid; Cynthia Whitman; Garth Fuller; Roger Bolus; Buddy Dennis; Rey Encarnacion; Bibiana Martinez; Jennifer Soares; Rushaba Modi; Nikhil Agarwal; Aaron Lee; Scott Kubomoto; Gobind Sharma; Sally Bolus; Lin Chang; Brennan M R Spiegel Journal: Int J Med Inform Date: 2015-07-26 Impact factor: 4.046
Authors: D A Drossman; Z Li; E Andruzzi; R D Temple; N J Talley; W G Thompson; W E Whitehead; J Janssens; P Funch-Jensen; E Corazziari Journal: Dig Dis Sci Date: 1993-09 Impact factor: 3.199
Authors: Christopher Adkins; Will Takakura; Brennan M R Spiegel; Mei Lu; Montserrat Vera-Llonch; James Williams; Christopher V Almario Journal: Clin Gastroenterol Hepatol Date: 2019-10-24 Impact factor: 11.382
Authors: Christopher V Almario; Samuel Eberlein; Carine Khalil; Brennan M R Spiegel Journal: Neurogastroenterol Motil Date: 2021-04-02 Impact factor: 3.598
Authors: Hisham Hussan; Jing Zhao; Abraham K Badu-Tawiah; Peter Stanich; Fred Tabung; Darrell Gray; Qin Ma; Matthew Kalady; Steven K Clinton Journal: PLoS One Date: 2022-03-10 Impact factor: 3.752